Trending News
News
News
New Gene Therapy Opportunities for Retinal Dystrophy
New opportunities towards gene therapy and diagnosis for the blinding eye disease, retinal dystrophy, may now become available following work done by the Eye Genetics Research Unit at Children’s Medical Research Institute.
News
Creating Tailored Cancer Vaccines With "Plug-and-Play" Tech
Scientists have created a pipeline for identifying, prioritizing and evaluating potential tumor antigens for the fast generation of cancer vaccines, according to research.
News
Deep-Sea Microbe Provides Rich Source of Anticancer Molecule
Researchers have uncovered how a marine bacterium makes a potent anti-cancer molecule known as salinosporamide A.
News
Vaccine Used To Treat – Rather Than Prevent – COVID-19
Doctors have successfully used vaccination to treat a patient with COVID-19 in what is thought to be the first instance of the vaccine being used for therapy instead of prevention.
News
Implementing Cellular Rejuvenation Therapy Reverses Signs of Aging in Mice
A combination of four reprogramming molecules that reset the epigenetic marks of older mice has been shown to reverse signs of aging with no side effects over time.
News
COVID-19 Vaccine Produced by Yeast Could Increase Accessibility
A new vaccine developed at MIT and Beth Israel Deaconess Medical Center may aid in efforts to vaccinate certain parts of the world, offering an inexpensive, easy-to-store and effective alternative to RNA vaccines.
News
Sneaking Drugs Into Cells Using a Protein-Based Microdroplet System
A team has developed a new way to deliver drugs into cells using large biological molecules, by enclosing them in a protein-based microdroplet.
News
CRISPR Vaccine Protects Against Leishmania Parasites
Research suggests that the parasites that cause cutaneous leishmaniasis may have met their match in vaccines developed using CRISPR.
News
Putting the Immune System on a Chip Could Help Tease Apart Its Complexities
Researchers have formed lymphoid follicles in a microfluidic Organ Chip device that replicate human immune functions and vaccine responses in vitro.
News
Priming the Tumor Environment To Improve Efficacy of Existing Therapeutics for Liver Cancer
Researchers have shown that by administering an immune checkpoint inhibitor to prime the tumor environment prior to a multikinase inhibitor, it's possible to boost the effectiveness of existing therapeutics for hepatocellular carcinoma.
Advertisement